In a move that underscores the changing landscape of the pharmaceutical industry, the chief trade group has officially accepted one of the world’s largest generic drug makers into its ranks.
Last Friday, Teva Pharmaceuticals became a member of the Pharmaceutical Research and Manufacturers of America, which has burnished its reputation on Capitol Hill and elsewhere as a staunch defender of brand-name companies.
The decision to accept Teva, which had been telegraphed in recent days, came as a surprise to some industry watchers, given the historical rivalry between brand-name and generic manufacturers.
About the Author Reprints
